Cargando…

p53 action in apoptosis and senescence

Detalles Bibliográficos
Autores principales:	Lowe, SW, Schmitt, CA, Ferbeyre, G, Lin, AW, de Stanchina, E, Soengas, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2000
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300840/ http://dx.doi.org/10.1186/bcr141

Ejemplares similares

Evading p53 action during tumor development and therapy
por: Lowe, SW
Publicado: (2005)

Inflammation, senescence and cancer: interweaving microRNA, inflammatory cytokines and p53 networks
por: Harris, Curtis C
Publicado: (2010)

p53-mediated apoptosis and genomic instability syndromes
por: Spillare, EA, et al.
Publicado: (2000)

Apoptosis factors caspases and p53 and their impact in chronic rhinosinusitis with nasal polyposis
por: Valera, Fabiana, et al.
Publicado: (2013)

T cells are depleted in HCV-induced hepatocellular carcinoma patients: possible role of apoptosis and p53
por: Ibrahim, Sherif A, et al.
Publicado: (2006)

Drug discovery in the p53 pathway
por: Lane, DP, et al.
Publicado: (2000)

SOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence
por: Mallette, Frédérick A., et al.
Publicado: (2010)

7.5 Safety data from over 1,200 patients-years of methotrexate and/or etanercept treatment in children with polyarticular or systemic juvenile rheumatoid arthritis
por: Giannini, EH, et al.
Publicado: (2008)

Activation of CDK4 by Tax chemosensitizes p53-mutant cells to DNA damage
por: Semmes, O John, et al.
Publicado: (2014)

SOCS1 regulates senescence and ferroptosis by modulating the expression of p53 target genes
por: Saint-Germain, Emmanuelle, et al.
Publicado: (2017)

Estrogen receptor alpha-positive and negative mouse mammary tumors through somatic mutations of p53 in mammary carcinogenesis
por: Lin, S-CJ, et al.
Publicado: (2003)

Prelamin accumulation in primary endothelial cells induces premature senescence and activation
por: Bonello-Palot, Nathalie, et al.
Publicado: (2015)

The role of coactivators in oestrogen action
por: Brown, M, et al.
Publicado: (2000)

TP53 and additional pathways in therapy resistance
por: Lønning, PE
Publicado: (2005)

OA01.46. Effect of LAS-02, a cancero-static compound on p53 levels in cases of different types of cancers
por: Singh, Vandana, et al.
Publicado: (2012)

Update on the FH01 study
por: Duffy, SW
Publicado: (2006)

Genetically altered mice and cancer research: effects of the other 99.999% of the genome and other variables upon phenotype
por: Barthold, SW
Publicado: (2003)

S5.3b Fungal spores: Initiators of colonization and infection
por: Baltussen, Tim, et al.
Publicado: (2022)

The impact of mammographic screening on breast cancer mortality: overview of the evidence so far
por: Gabe, R, et al.
Publicado: (2004)

Antimalarial chloroquine metamorphosed into antiviral agent against HIV with four modes of actions
por: Chandramohan, M, et al.
Publicado: (2012)

S5.3c Investigating the link between pleomorphism and virulence in Cryptococcus
por: Fernandes, Kenya, et al.
Publicado: (2022)

S5.3a Unraveling the genetic determinants of virulence in Cryptococcus neoformans
por: Jackson, Katrina, et al.
Publicado: (2022)

Regulating apoptosis in fibroblasts
por: Pap, T, et al.
Publicado: (2005)

P472 The mechanism of action of antifungal activity of Zanthoxylum armatum fruit's oil against Candida cells does not involve ROS generation
por: Pasrija, Ritu
Publicado: (2022)

IFN-α suppresses HTLV-1 expression via PKR in infected cells and renders them susceptible to AZT through p53 activation in AZT/IFN-α treatment
por: Kinpara, Shuichi, et al.
Publicado: (2014)

A single nucleotide polymorphism in the HDM-2 gene regulates the p53 apoptotic response and influences the age of onset of cancers in humans: the SNP 309 HDM-2 polymorphism
por: Bond, GL, et al.
Publicado: (2005)

D133P53, directly transactivated by p53, prevents p53-mediated apoptosis without inhibiting p53-mediated cell cycle arrest
por: Aoubala, M, et al.
Publicado: (2010)

Dual actions of ANP on endothelial permeability
por: Chen, Wen, et al.
Publicado: (2013)

Origin of the kink of somatic action potentials
por: Teleńczuk, Maria T, et al.
Publicado: (2015)

Molecular control of apoptosis in the breast
por: Streuli, C, et al.
Publicado: (2000)

What affects the bone in our HIV-positive patients?
por: Fux, CA
Publicado: (2010)

P060 A preliminary in vitro and in vivo evaluation of the effect and action mechanism of 17-AAG combined with azoles against azole-resistant Candida spp.
por: Liu, Md Luyao
Publicado: (2022)

Antimalarial activity of ulein and proof of its action on the Plasmodium falciparum digestive vacuole
por: de Oliveira, Alaíde Braga, et al.
Publicado: (2010)

New mechanisms of action and signaling by TNF-α
por: Ivashkiv, Lionel B
Publicado: (2012)

HIV-1 Tat and T cell apoptosis
por: Krammer, Peter H
Publicado: (2006)

Lessons from TP53 mutations in breast cancers: from carcinogen fingerprints to clinical correlates
por: Hainaut, P, et al.
Publicado: (2000)

O085: A network-based approach using intra-hospital patient transfers to identify high-risk wards during nosocomial outbreaks
por: Ciccolini, M, et al.
Publicado: (2013)

Thoracoscopic surgical management of esophageal benign tumor
por: Jeon, HW, et al.
Publicado: (2013)

O095: Isolation videoclip for visitors and patients
por: Ana, BS, et al.
Publicado: (2013)

Dissemination of Cost Action FP0905 information by website
por: Migliacci, Fabio, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_dd4hn3ba2rl3ie5d84athi4at3